Reckitt Benckiser Group plc buy Sargnagel
Start price
29.01.18
/
50%
€77.08
Target price
04.11.21
€100.00
Performance (%)
-7.76%
End price
05.11.21
€71.10
Summary
This prediction ended on 05.11.21 with a price of €71.10. With a performance of -7.76%, the BUY prediction by Sargnagel finished with a loss. Dividends of €8.66 are taken into consideration when calculating the performance. Sargnagel has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Reckitt Benckiser Group plc | 6.647% | 6.647% | -30.321% | -33.769% |
| iShares Core DAX® | 1.804% | -0.748% | 13.168% | 16.408% |
| iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% | 43.502% |
| iShares Nikkei 225® | 0.413% | -7.381% | 18.776% | 2.874% |
| iShares S&P 500 | 0.664% | -1.941% | 28.141% | 42.155% |
Comments by Sargnagel for this prediction
In the thread Reckitt Benckiser Group plc diskutieren
Produkte für den Haushalt, Gesundheit und mehr
Weltweit tätiger Konzern mit zahlreichen Markenartikeln im Portfolio unter anderem Finish, Lysol, Dettol, Vanish, Woolite, Durex, Calgon, Airwick, Harpic, Bang, Mortein, Veet, Nurofen, Clearasil, Strepsils, Gaviscon, Mucinex, Scholl und French'ster.
Kursziel geändert auf 100,0
In the thread Trading Reckitt Benckiser Group plc
Die von Sargnagel gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Sargnagel for Reckitt Benckiser Group plc
Reckitt Benckiser Group plc
Start price
Target price
Perf. (%)
€80.09
12.05.15
12.05.15
€111.00
20.12.17
20.12.17
1.98%
20.12.17
20.12.17
